Skip to Main Content Skip to Site Map Skip to Accessibility Statement

DREAM

 

Trial Acronym DREAM
Trial Title Determining the Role of Synthetic Cannabinoids in Eye Pressure And Tolerability Measurements (DREAM)
Clinical Area Ophthalmology
Trial Status Set Up
Chief Investigator (CI) Professor Augusto Azuara-Blanco, Queen’s University Belfast
Sponsor Belfast Health and Social Care Trust
Funder Glaucoma UK

Public Health Agency (PHA), Health and Social Care (HSC) Research & Development Division, Northern Ireland

 

For any queries regarding this trial please contact the study email (DREAM@nictu.hscni.net) or call the NICTU (028 9615 1447).

Quick Links

Services